Observational Study - ILM Peeling
Completed
- Conditions
- Epimacular GliosisMacular Hole
- Registration Number
- NCT01083056
- Lead Sponsor
- University Hospital Tuebingen
- Brief Summary
This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Clinical diagnosis of Epimacular Gliosis
- Must be scheduled for ILM-peeling independently of study
- Must be older then 18 years of age
Exclusion Criteria
- Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
- Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BCVA 6 months after ILM peeling
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular changes occur in the retina after epimacular membrane peeling in NCT01083056?
How does epimacular membrane peeling compare to standard-of-care treatments for macular hole and epimacular gliosis?
Are there specific biomarkers that correlate with improved retinal function post-epimacular membrane peeling in NCT01083056?
What are the potential adverse events associated with epimacular membrane peeling in retinal disorders?
What are the current therapeutic strategies for epimacular gliosis and macular hole besides the observational approach in NCT01083056?
Trial Locations
- Locations (1)
Centre for Ophthalmology, University Hospital Tuebingen
🇩🇪Tuebingen, BW, Germany
Centre for Ophthalmology, University Hospital Tuebingen🇩🇪Tuebingen, BW, Germany